A recombinant human IgG1 Fc multimer designed to mimic the active fraction of IVIG in autoimmunity
Xiaoyu Zhang(Agilent Technologies (United States)), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Denis Rybin(Boston University), Emmanuel Y. Mérigeon(Gliknik (United States)), Erin Burch(Syngenta (United States)), Donald Bennett(Pfizer (United States)), Jane Owens(Pfizer (United States)), Hua Zhou(Guangzhou University of Chinese Medicine), Henrik S. Olsen(Gliknik (United States)), David S. Block(Gliknik (United States)), Xianfeng Li(Peking University), Haiping Hao(Johns Hopkins University), Gregory J. LaRosa(Pfizer (United States)), Mark C. McCroskey(Pfizer (United States)), Edward So(University of Maryland, Baltimore), Gregory L. Weber(Pfizer (United States))
Cited by 29
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
The trans-ancestral genomic architecture of glycemic traits
|Nature Genetics|2021|908
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|548